Febrile Urinary Tract Infections Common With Neurogenic Bladder
WEDNESDAY, March 8, 2023 (HealthDay News) — Recurrent febrile urinary tract infections (FUTIs) are common in children with neurogenic bladder, and the risk for rapid progression to chronic kidney disease (CKD) increases in a dose-response manner, acc…
Learn MoreCOVID Raises Odds for Long-Term Gastro Problems
WEDNESDAY, March 8, 2023 (HealthDay News) — Add gastrointestinal problems to the long list of lingering conditions that can follow COVID-19.New research has found that people who have had COVID-19 are at an increased risk of gastrointestinal disorder…
Learn MoreGene That Shielded Some Against Black Death May Be Helping, Harming People Today
WEDNESDAY, March 8, 2023 (HealthDay News) — Some people may have a gene that helps protect them from respiratory diseases like COVID-19 — and helped their ancestors fight the plague.It comes at a cost.This same gene variation may be linked to an inc…
Learn MoreTras un brote infeccioso, los expertos ofrecen orientación sobre el uso seguro de las gotas para los ojos
LUNES, 6 de marzo de 2023 (HealthDay News) — Un brote de unas infecciones bacterianas graves en 13 estados de EE. UU., vinculado con el uso de lágrimas artificiales, ha llevado a los expertos a ofrecer consejos para mantener seguros a los ojos secos….
Learn MoreUno de cada cuatro padres de EE. UU. mintió sobre el estatus de COVID de su hijo
LUNES, 6 de marzo de 2023 (HealthDay News) — Las autoridades de salud pública ofrecieron muchos consejos para prevenir la propagación de la COVID-19 a principios de la pandemia, pero parece que muchos padres se hicieron de oídos sordos.Alrededor de 1…
Learn MoreTwo More Brands of Eyedrops Recalled Over Infection Risks
TUESDAY, March 7, 2023 (HealthDay News) — U.S. Federal health officials have issued recall notices for two more brands of eyedrops.In the latest round of recalls, the U.S. Food and Drug Administration posted notices after the companies voluntarily pu…
Learn MoreClinical Treatment Considerations Presented for Severe Mpox
TUESDAY, March 7, 2023 (HealthDay News) — In a report published in the March 3 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, interim clinical treatment considerations are presented for severe mani…
Learn MoreBreakthrough SARS-CoV-2 Similar for Chronic Liver Disease With, Without Cirrhosis
TUESDAY, March 7, 2023 (HealthDay News) — Full vaccination cuts the risk for all-cause mortality for breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among chronic liver disease (CLD) patients with cirrhosis by two-…
Learn MoreMotavizumab, Nirsevimab, Palivizumab Beneficial for RSV Prevention
TUESDAY, March 7, 2023 (HealthDay News) — Significant benefits are seen with motavizumab, nirsevimab, and palivizumab for prevention of respiratory syncytial virus (RSV) in infants and children, according to a review published online Feb. 17 in JAMA …
Learn More